Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
about
Immunotherapy for head and neck squamous cell carcinomaPrognostic significance of tumor infiltrating immune cells in oral squamous cell carcinomaPrognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma.The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma.Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.CD68/macrosialin: not just a histochemical marker.Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.Prognostic value of CD45 transcriptional expression in head and neck cancer.Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.A correlative analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 expression in oropharyngeal squamous cell carcinoma.Checkpoint immunotherapy in head and neck cancers.Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer.IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.Pan-cancer deconvolution of tumour composition using DNA methylationTreatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapyImmune and genomic signatures in oral (head and neck) cancerPrognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysisEGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancerDeciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review
P2860
Q26739850-4D9BB5EC-6C6E-4E7C-A806-2C5CC46EC0FCQ33733725-D608351E-1E9B-4638-8832-ADB244512904Q37439587-3EDC12FF-C8BA-4040-9404-B2AB5F3F22BAQ37441444-558121CD-A360-4C93-AE6F-8BC2DDAB213BQ37684668-628AE61A-00B4-48DB-8218-4216F2E80A2AQ37697218-4494F3EC-011E-4AB4-95E6-691F0192EF36Q37702039-8873A534-A70E-414C-9C82-68D4AD2B0BC8Q37713070-AAD26B50-E633-46E7-A74A-6DCC6C227839Q37718331-869E5EA9-50FC-49F1-A208-51232A81E209Q38935248-D4D571D3-10D9-40AC-9971-C7D7C3D2C4A9Q40442574-001A52EC-F272-4C08-AFD5-3423CD31DC9CQ40475503-A786743F-6C3A-4955-B3A7-21018B8C0083Q41206627-0FE94B46-93BD-4375-9FD1-360E7832C49AQ41431266-04AA52D5-C5E6-4DAB-8FD9-441475FEA9EBQ41934319-64B7E3BB-9896-418B-AF84-F55277DCC65EQ42365249-7174D7A6-C546-42C7-BE98-AF79648DE3BFQ47320798-61470F8D-2D67-45EF-B156-E5C3E5E059BDQ47361788-21217CBD-31AF-4ED5-89FE-8642B22EB130Q47393395-B3506813-CC49-4F9C-BCF3-82E3B15108DBQ47683846-5D184731-F334-487C-ADD4-F14707807033Q48249876-54870B00-0D73-4954-B0B9-564B8892CB85Q48307824-6F7E4BBF-AB55-4A36-A310-17F0D0A559FDQ50027076-C7617D28-E6E6-4223-A60A-B53177AB8EF2Q53098427-D36E7076-A104-4AD4-A099-951B185284AAQ54256927-E6B6B612-3E02-40BD-B7BE-14813FA5CCEBQ55385663-D9289FA0-EB99-41B9-AB6A-E78E816E6E56Q55515909-B70B320A-502F-4938-A27F-FC160FAF310BQ56890466-109985B1-F0E7-4ACA-ABFD-29C676C8315CQ57138281-951D1C41-4F32-4F8D-A482-FF8AACFC39DCQ58700648-EE2DD12B-F076-49A4-8D0C-A4E0CE1E8E6CQ58759331-CD37CDFE-0C42-453B-8357-A574E89060FEQ58760097-AE892995-3439-4705-B924-9A8DF7EA30FEQ59127669-8E7659F2-C068-4E4C-9C08-48ABD15C9B1A
P2860
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumor infiltrating lymphocytes ...... neck squamous cell carcinoma.
@en
type
label
Tumor infiltrating lymphocytes ...... neck squamous cell carcinoma.
@en
prefLabel
Tumor infiltrating lymphocytes ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Tumor infiltrating lymphocytes ...... neck squamous cell carcinoma.
@en
P2093
Carol R Bradford
Daffyd Thomas
Daniel Perim
Emily Bellile
Gregory T Wolf
Head and Neck SPORE Program Investigators
Heather Walline
Jeffery Moyer
Jeremy M G Taylor
Jonathan McHugh
P2860
P304
P356
10.1002/HED.24406
P577
2016-02-16T00:00:00Z